Specialty pharmaceutical manufacturing focuses on developing and distributing unique medications tailored for specific patient needs. These companies typically innovate in creating treatments for complex diseases, particularly where mainstream pharmaceuticals fall short. As the demand for personalized medicine grows, so does the outlook for this industry, which emphasizes quality, safety, and efficacy. Market trends indicate a shift toward biopharmaceuticals and biologics, propelling investments into R&D and novel therapeutic approaches. Emerging technologies in drug delivery and diagnostics are set to redefine success in this space, offering manufacturers new avenues for addressing pressing health challenges.


This list features 24 prominent specialty pharmaceutical manufacturers, showcasing companies varying in size, location, and expertise. The firms span multiple countries, from established giants like Intas Pharmaceuticals in India to innovative players like Acceleron Pharma in the United States. Established between 1929 and 2022, they specialize in areas such as oncology, rare diseases, and immunotherapy, reflecting a growing trend towards targeted treatment solutions. These manufacturers employ thousands of individuals and are dedicated to advancing patient care through research and development, thereby influencing the global healthcare market significantly.


Keep reading to discover the top specialty pharmaceutical manufacturers.


Top 24 Specialty Pharmaceutical Manufacturing Companies


1. Intas Pharmaceuticals

  • Website: intaspharma.com
  • Ownership type: Private Equity
  • Headquarters: Ahmedabad, Gujarat, India
  • Employee distribution: India 99%, Other 1%
  • Latest funding: October 2022
  • Founded year: 2000
  • Headcount: 10001+
  • LinkedIn: intas-biopharmaceuticals

Intas Pharmaceuticals Limited, founded in 2000 and based in Ahmedabad, Gujarat, India, is a pharmaceutical company that specializes in the development, manufacturing, and marketing of generic therapeutic drugs. With a workforce exceeding 17,000 employees, Intas operates primarily in India, but its reach extends to over 85 countries worldwide. The company is dedicated to addressing unmet medical needs through innovative products and a strong commitment to quality. Intas has established a comprehensive pharmaceutical value chain, which includes a significant focus on research and development. They invest around 6-7% of their turnover annually into R&D, employing over 550 scientists and researchers across 17 advanced facilities. Their product portfolio includes a range of formulations, from tablets to injectables, and they have made notable strides in biosimilars and oncology. Intas is recognized for its high-quality standards, with manufacturing facilities approved by major global regulatory agencies, including the USFDA and EMA.


2. Chiesi Group

  • Website: chiesi.com
  • Ownership type: Private
  • Headquarters: Parma, Emilia-Romagna, Italy
  • Employee distribution: Italy 64%, Pakistan 3%, United Kingdom (UK) 3%, Other 30%
  • Founded year: 1935
  • Headcount: 5001-10000
  • LinkedIn: chiesi-group

Chiesi Group, officially known as Chiesi Farmaceutici S.p.A., is an international biopharmaceutical company headquartered in Parma, Italy. Founded in 1935, the company has over 85 years of experience in the pharmaceutical industry. Chiesi specializes in the research, development, and commercialization of innovative therapeutic solutions, particularly targeting respiratory health, rare diseases, and specialty care. With a workforce of approximately 5,751 employees, Chiesi operates in more than 100 countries and has a direct presence in 31 of them. The company emphasizes a strong commitment to sustainability and social responsibility, having adopted the status of a Benefit Corporation in 2018 and achieving B Corp certification in 2019. Their research and development efforts are supported by multiple centers across the globe, including locations in the United States, Canada, and China, which facilitate their clinical and regulatory programs. Chiesi's production facilities are strategically located in Parma, Italy, Blois, France, and Santana de Parnaíba, Brazil, ensuring efficient manufacturing capabilities to meet global demand.


3. Seattle Genetics


Seattle Genetics, founded in 1998 and based in Bothell, Washington, is a biopharmaceutical company that focuses on developing and manufacturing innovative therapies for cancer treatment. The company is particularly known for its pioneering work in antibody-drug conjugates (ADCs), which combine targeted antibodies with potent cytotoxic drugs to deliver treatment directly to cancer cells. This approach aims to minimize damage to healthy tissue while maximizing the therapeutic effect on tumors. Seattle Genetics has successfully brought several ADCs to market, including Adcetris, which is used to treat certain types of lymphoma. The company is committed to advancing cancer care through extensive research and development efforts, and it collaborates with various partners to enhance its product pipeline and expand its reach in the oncology market.


4. Eisai Co., Ltd.


Eisai Co., Ltd., founded in 1941 and based in Bunkyo City, Tokyo, Japan, is a pharmaceutical company dedicated to drug discovery and development. The company specializes in creating innovative treatments primarily in the fields of oncology and neurology. Eisai's mission is to enhance patient outcomes and access to medicines through rigorous research and development efforts. With a workforce of approximately 622 employees, the company operates globally, with significant presence in Japan, Vietnam, the United States, and other countries. Eisai is actively involved in clinical trials and has a robust pipeline of new therapies, including recent advancements in treatments for Alzheimer's disease. Their commitment to sustainability and improving access to medicines in developing regions further underscores their role in the pharmaceutical industry.


5. Blau Farmacêutica

  • Website: blau.com.br
  • Ownership type: Private
  • Headquarters: Cotia, Sao Paulo, Brazil
  • Founded year: 1987
  • Headcount: 1001-5000
  • LinkedIn: blausiegel

Blau Farmacêutica, founded in 1987 and based in Cotia, São Paulo, Brazil, is a private pharmaceutical company that specializes in high-complexity medications and biotechnology solutions. The company serves hospitals and healthcare providers across Latin America and the United States, focusing on innovative therapies designed to improve patient care and reduce treatment side effects. With a workforce of approximately 959 employees, Blau operates five manufacturing facilities in Brazil, equipped with advanced technology and adhering to stringent quality standards set by international regulatory agencies. The company has developed a comprehensive portfolio of medications that address critical areas such as oncology, hematology, immunology, and anesthesiology. Blau is also involved in the biotechnology sector, emphasizing research and development to create cutting-edge solutions for healthcare. Their commitment to quality and safety is evident in their operational practices and product offerings, positioning them as a significant player in the pharmaceutical industry.


6. Kedrion Biopharma

  • Website: kedrion.com
  • Ownership type: Private Equity
  • Headquarters: Fort Lee, New Jersey, United States (USA)
  • Employee distribution: Italy 49%, United States (USA) 27%, United Kingdom (UK) 14%, Other 11%
  • Latest funding: September 2022
  • Founded year: 2001
  • Headcount: 1001-5000
  • LinkedIn: kedrion-biopharma

Kedrion Biopharma is a biopharmaceutical company based in Fort Lee, New Jersey, established in 2001. The company specializes in the collection and fractionation of blood plasma to produce and distribute plasma-derived therapies aimed at treating rare and debilitating diseases, such as coagulation disorders and immunodeficiencies. Kedrion operates on a global scale, with production facilities in multiple countries and a network of plasma collection centers in the United States and the Czech Republic. The company has expanded its capabilities through strategic acquisitions, including the purchase of Bio Products Laboratory in 2022, enhancing its portfolio of therapies for rare diseases. Kedrion is dedicated to maintaining high industry standards and ensuring the safety and quality of its products, which are distributed in over 100 countries worldwide.


7. Par Pharmaceutical

  • Website: parpharm.com
  • Ownership type: Corporate
  • Headquarters: Chestnut Ridge, New York, United States (USA)
  • Employee distribution: India 57%, United States (USA) 42%
  • Latest funding: $8.1B, May 2015
  • Founded year: 1978
  • Headcount: 501-1000
  • LinkedIn: par-pharmaceutical

Par Pharmaceutical, a subsidiary of Endo International, is based in Chestnut Ridge, New York. Founded in 1978, the company specializes in creating life-enhancing therapies across various medical fields, including urology, orthopedics, and pediatric endocrinology. Par Pharmaceutical is dedicated to specialty medicines, sterile injectables, and generics, serving healthcare providers, hospitals, and patients. Their robust research and development efforts are aimed at addressing unmet medical needs, and they maintain a significant presence in the pharmaceutical market with a workforce of approximately 1,415 employees. The company has a strong manufacturing capability, with facilities that support their commitment to quality and compliance in producing high-quality medications. Par Pharmaceutical's focus on patient-centric solutions and innovative therapies positions it as a relevant entity in the specialty pharmaceutical industry.


8. Acceleron Pharma

  • Website: acceleronpharma.com
  • Ownership type: Corporate
  • Headquarters: Cambridge, Massachusetts, United States (USA)
  • Employee distribution: United States (USA) 94%, Canada 6%
  • Latest funding: $11.5B, September 2021
  • Founded year: 2003
  • Headcount: 201-500
  • LinkedIn: acceleron-pharma

Acceleron Pharma, founded in 2003 and based in Cambridge, Massachusetts, is a biotechnology company dedicated to developing innovative therapies for rare diseases. The company has made significant strides in the field of hematology and pulmonary medicine, focusing on conditions that often lack effective treatment options. Acceleron is known for its research and development efforts, particularly in the area of protein therapeutics. In 2021, the company was acquired by Merck & Co., Inc., which has further expanded its capabilities and resources. This acquisition allows Acceleron to leverage Merck's extensive infrastructure while continuing to pursue its mission of addressing critical health challenges. The company has received substantial funding, with a reported last funding amount of $11.5 billion, indicating strong investor confidence in its potential to deliver impactful therapies.


9. NPS Pharma

  • Website: shire.com
  • Ownership type: Corporate
  • Headquarters: Bedminster, New Jersey, United States (USA)
  • Employee distribution: United States (USA) 51%, Algeria 12%, Ireland 12%, Other 25%
  • Latest funding: $86.4B, April 2018
  • Founded year: 1986
  • Headcount: 201-500
  • LinkedIn: nps-pharmaceuticals

NPS Pharma, originally founded in 1986, is a pharmaceutical company based in Bedminster, New Jersey. It specializes in the research, development, manufacturing, and marketing of innovative medicines. The company has a strong focus on therapeutic areas that include gastrointestinal diseases, rare diseases, oncology, and vaccines. NPS Pharma aims to address unmet medical needs and improve patient outcomes through its specialized products. In 2018, the company was acquired by Takeda Pharmaceutical Company Limited, which has expanded its reach and capabilities in the pharmaceutical industry. NPS Pharma's commitment to transforming lives is evident in its ongoing research and development efforts, particularly in the field of rare diseases, where it seeks to provide treatment options for patients with limited alternatives.


10. Esteve

  • Website: esteve.com
  • Ownership type: Corporate
  • Headquarters: Barcelona, Catalonia, Spain
  • Employee distribution: Spain 86%, Mexico 6%, France 3%, Other 6%
  • Latest funding: June 2023
  • Founded year: 1929
  • Headcount: 1001-5000
  • LinkedIn: esteve

Esteve, founded in 1929 and headquartered in Barcelona, Spain, is a pharmaceutical company dedicated to developing and manufacturing innovative medications aimed at treating serious diseases. With a workforce of approximately 1,937 employees, Esteve operates primarily in Spain, with a notable presence in Mexico, France, and other countries. The company specializes in therapeutic areas such as oncology and neurology, and it also offers contract manufacturing and research services. Esteve has made significant strides in expanding its portfolio, particularly through the acquisition of HRA Pharma Rare Diseases, which enhances its offerings in the treatment of rare and severe diseases. Esteve's commitment to research and development is evident in its robust pipeline and collaborations with various healthcare providers and pharmaceutical companies. The company is focused on improving patient outcomes and has a clear strategy for growth in the specialty pharmaceutical market.


11. EUSA Pharma

  • Website: eusapharma.com
  • Ownership type: Corporate
  • Headquarters: Hemel Hempstead, England, United Kingdom (UK)
  • Employee distribution: United Kingdom (UK) 47%, France 17%, Spain 13%, Other 24%
  • Latest funding: $847.9M, December 2021
  • Founded year: 2006
  • Headcount: 201-500
  • LinkedIn: eusa-pharma

EUSA Pharma is a biopharmaceutical company based in Hemel Hempstead, England, established in 2006. The company specializes in developing innovative treatments primarily for oncology and rare diseases. EUSA Pharma operates on a global scale, providing therapies such as SYLVANT® (siltuximab) and QARZIBA® (dinutuximab beta) to healthcare providers and patients. Their focus is on addressing the needs of patients who have limited treatment options, showcasing their commitment to improving patient outcomes. EUSA Pharma is part of Recordati Rare Diseases, which enhances its capabilities in research, development, and marketing of pharmaceuticals. The company has also received substantial funding, with the last reported amount being approximately $848 million in December 2021, indicating strong investor confidence in their mission and potential for growth.


12. Laboratorios Bagó

  • Website: bago.com.ar
  • Ownership type: Private
  • Headquarters: General Pacheco, Buenos Aires, Argentina
  • Employee distribution: Argentina 70%, Brazil 6%, Ecuador 4%, Other 19%
  • Founded year: 1934
  • Headcount: 5001-10000
  • LinkedIn: laboratorios_bago

Laboratorios Bagó is a prominent pharmaceutical company based in General Pacheco, Buenos Aires, Argentina. Founded in 1934, it has grown significantly over the decades, focusing on the development and manufacturing of prescription and over-the-counter medications. The company prides itself on its commitment to research and development, which is reflected in its 148 patents and innovative healthcare solutions. Laboratorios Bagó serves healthcare professionals, hospitals, and patients, aiming to enhance health outcomes through effective pharmaceutical products. With operations in 20 countries and products available in 50, the company has established a solid international presence. Its dedication to quality and excellence is underscored by adherence to stringent pharmacotechnical and clinical evaluations, ensuring that its offerings meet high international standards. Laboratorios Bagó continues to play a vital role in the pharmaceutical industry, contributing to advancements in medical technology and patient care.


13. PROBIOMED S.A. de C.V.

  • Website: probiomed.com.mx
  • Ownership type: Corporate
  • Headquarters: Mexico
  • Employee distribution: Mexico 99%
  • Latest funding: May 2022
  • Founded year: 1970
  • Headcount: 501-1000
  • LinkedIn: probiomedmx

PROBIOMED S.A. de C.V. is a Mexican biopharmaceutical company established in 1970. The company is dedicated to the research, development, manufacturing, and commercialization of pharmaceutical products that cater to human health. With a workforce of approximately 657 employees, PROBIOMED focuses on creating high-tech biopharmaceutical products aimed at treating serious diseases. Their product offerings include a wide range of therapies for conditions such as cancer, chronic kidney disease, rheumatoid arthritis, multiple sclerosis, and diabetes. The company emphasizes the importance of making effective treatments accessible to patients worldwide. PROBIOMED's portfolio features a variety of chemical synthesis generics and biocomparables, including cytokines, monoclonal antibodies, fusion proteins, and recombinant vaccines, which are essential for the prevention and treatment of autoimmune diseases, chronic degenerative disorders, hematological and metabolic disorders, as well as malignant neoplasms. Their commitment to quality and safety is reflected in their adherence to pharmacovigilance practices, ensuring that their products meet the highest standards for patient care.


14. Mundipharma

  • Website: mundipharma.com
  • Ownership type: Corporate
  • Headquarters: Cambridge, England, United Kingdom (UK)
  • Employee distribution: United Kingdom (UK) 27%, United Arab Emirates 6%, Brazil 5%, Other 63%
  • Latest funding: June 2023
  • Founded year: 1952
  • Headcount: 1001-5000
  • LinkedIn: mundipharma

Mundipharma International Limited, founded in 1952 and headquartered in Cambridge, England, is a multinational pharmaceutical company that specializes in research-based drug development. The company is dedicated to providing innovative treatments for various health conditions, with a strong emphasis on pain management and oncology. Mundipharma's product portfolio includes medications for pain relief, biosimilars, and therapies for respiratory and central nervous system disorders. The company operates globally, with a presence in over 120 countries, and focuses on collaboration and partnerships to enhance patient care. Recently, Mundipharma has shifted its focus back to its prescription portfolio after selling its Consumer Health business to iNova Pharmaceuticals, reinforcing its commitment to specialty care. The company employs over 2,100 people and is actively involved in clinical trials and late-phase development, showcasing its dedication to bringing new therapies to market.


15. Medexus Pharmaceuticals

  • Website: medexuspharma.com
  • Ownership type: Private
  • Headquarters: Chicago, Illinois, United States (USA)
  • Employee distribution: United States (USA) 50%, Canada 50%
  • Founded year: 2012
  • Headcount: 51-200
  • LinkedIn: medexuspharma

Medexus Pharmaceuticals, Inc. is a private pharmaceutical company based in Chicago, Illinois, with a significant operational footprint in North America. Founded in 2012, the company specializes in innovative specialty products aimed at improving health outcomes for patients with various diseases, including rare conditions. Medexus offers a range of prescription and over-the-counter medications, with a focus on therapeutic areas such as allergy, dermatology, hematology, oncology, and rheumatology. The company operates through two segments: Medexus Pharma Canada and Medexus Pharma USA, allowing them to effectively serve healthcare professionals and patients across both countries. Their product portfolio includes notable offerings like Rasuvo, IXINITY, and Gleolan, which cater to specific medical needs. Medexus has built a robust commercial platform supported by a fully integrated infrastructure that includes regulatory, medical affairs, and sales operations, positioning them for future growth in the specialty pharmaceutical market.


16. Zodiac Produtos Farmacêuticos


Zodiac Produtos Farmacêuticos, now known as Adium, is a pharmaceutical company headquartered in São Paulo, Brazil. Established in 1991, Adium specializes in developing and manufacturing innovative therapeutic solutions aimed at addressing various medical conditions. Their product portfolio includes medications for pain management, oncology, rare diseases, and more, all designed to enhance the quality of life for patients. The company operates in multiple countries across Latin America, ensuring that healthcare professionals and patients have access to high-quality treatments. Adium is committed to research and development, investing in clinical studies to ensure the safety and efficacy of their products. With a workforce of approximately 754 employees, the company emphasizes a culture of compliance and ethical practices, which is crucial in the pharmaceutical industry. Their manufacturing facilities are equipped with advanced technology and adhere to stringent quality standards, further solidifying their position in the market.


17. Adamed Pharma

  • Website: adamed.com
  • Ownership type: Private
  • Headquarters: Warsaw, Masovian Voivodeship, Poland
  • Employee distribution: Poland 92%, Spain 3%, Other 5%
  • Founded year: 1986
  • Headcount: 1001-5000
  • LinkedIn: adamed

Adamed Pharma S.A. is a Polish pharmaceutical and biotechnology company founded in 1986, with its headquarters in Warsaw. The company employs approximately 1,500 people and operates primarily in Poland, with a small presence in Spain and other countries. Adamed Pharma specializes in developing and manufacturing high-quality medicinal products that target chronic diseases. Their product portfolio includes prescription medications, over-the-counter drugs, dietary supplements, dermocosmetics, and medical devices. The company prides itself on its innovative approach, leveraging Polish scientific thought and its own patents to create effective healthcare solutions. Adamed Pharma is also involved in research and development, focusing on original drug development and enhancing existing therapies. The company has a strong commitment to corporate social responsibility, reflected in its various social programs and initiatives aimed at improving health outcomes. Adamed's products are available in numerous markets worldwide, showcasing its global reach and operational capabilities.


18. MSD Sharp & Dohme GmbH

  • Website: msd.de
  • Ownership type: Private
  • Headquarters: Amt Neuhaus, Lower Saxony, Germany
  • Founded year: 2001
  • Headcount: 1001-5000
  • LinkedIn: msd-sharp-%26-dohme-gmbh

MSD Sharp & Dohme GmbH, a subsidiary of Merck & Co., Inc., is a pharmaceutical company based in Amt Neuhaus, Lower Saxony, Germany. Founded in 2001, the company specializes in the research, development, and manufacturing of medications and vaccines. MSD is particularly focused on addressing health challenges in oncology and infectious diseases, striving to provide innovative solutions that enhance patient care. With a workforce of approximately 2,438 employees, MSD is recognized as one of the prominent pharmaceutical manufacturers in Germany. The company is dedicated to improving global health outcomes by ensuring that their products are accessible to healthcare providers and patients alike. Their commitment to clinical research and the development of new therapies underscores their role in advancing healthcare solutions.


19. GSK Canada

  • Website: gsk.ca
  • Ownership type: Private
  • Headquarters: Mississauga, Ontario, Canada
  • Founded year: 1906
  • Headcount: 1001-5000
  • LinkedIn: gsk-canada

GSK Canada, based in Mississauga, Ontario, is a biopharmaceutical company with a rich history dating back to 1906. The company specializes in developing innovative vaccines and specialty medicines aimed at improving health outcomes for patients. GSK Canada is particularly focused on therapeutic areas such as infectious diseases, oncology, and immunology. They have invested over $2 billion in pharmaceutical and vaccine research and development in Canada since 2001, demonstrating a strong commitment to advancing healthcare solutions. Their product offerings include a range of specialty medicines, such as Benlysta for lupus and Jemperli for certain types of cancer, showcasing their expertise in addressing complex health conditions. GSK Canada operates under the larger GSK plc umbrella, which enhances its capabilities in research and development, allowing for the rapid advancement of new therapies.


20. Italfarmaco S.P.A.

  • Website: italfarmaco.com
  • Ownership type: Family Owned
  • Headquarters: Cinisello Balsamo, Lombardy, Italy
  • Employee distribution: Italy 93%, Other 7%
  • Founded year: 1938
  • Headcount: 501-1000
  • LinkedIn: italfarmaco-s.p.a.

Italfarmaco S.P.A., founded in 1938 and based in Cinisello Balsamo, Lombardy, Italy, is a family-owned pharmaceutical company dedicated to enhancing healthcare through innovative solutions. The company specializes in the development, manufacture, and marketing of both prescription and non-prescription products. Italfarmaco places a strong emphasis on research and development, particularly targeting rare diseases, which are often overlooked by larger pharmaceutical firms. Their mission is to create effective treatments that improve patient outcomes and accessibility to healthcare. With a workforce of approximately 502 employees, Italfarmaco operates production facilities in Italy, Spain, and Chile, ensuring high-quality standards in their medicinal specialties. The company is also involved in strategic partnerships to expand its reach and enhance its product offerings, demonstrating a proactive approach to growth in the pharmaceutical industry.


21. Dompé

  • Website: dompe.com
  • Ownership type: Private
  • Headquarters: Milan, Lombardy, Italy
  • Employee distribution: Italy 69%, United States (USA) 20%, Albania 10%, Other 1%
  • Founded year: 1940
  • Headcount: 501-1000
  • LinkedIn: dompe

Dompé is a privately-owned pharmaceutical and biotechnology company based in Milan, Italy, founded in 1940. With a workforce of approximately 1,020 employees, the company is dedicated to developing and manufacturing innovative treatments for complex medical conditions. Dompé has carved a niche in areas such as ophthalmology and pain management, focusing on high-need therapeutic areas. Their notable product, cenegermin, is a recombinant human nerve growth factor used to treat Neurotrophic Keratitis, a rare degenerative eye disease. The company operates a production facility in L’Aquila, Italy, which is equipped to handle both over-the-counter drugs and specialized biotech products. Dompé emphasizes collaboration with the scientific community and invests in research and development to advance drug therapies that can significantly impact patient care. Their commitment to addressing unmet medical needs positions them as a relevant player in the specialty pharmaceutical sector.


22. Macleods Pharmaceuticals LTD.


Macleods Pharmaceuticals LTD., founded in 1989 and based in Mumbai, Maharashtra, India, is a private pharmaceutical company with over 10,000 employees. The company develops, manufactures, and markets a wide range of pharmaceutical products, focusing on therapeutic areas such as anti-infectives, cardiovascular, and anti-diabetic medications. Macleods operates multiple manufacturing units that adhere to stringent quality standards, ensuring compliance with both Indian and international regulatory requirements. Their robust research and development capabilities support the creation of active pharmaceutical ingredients (APIs) and formulations, enhancing their product offerings. With a global presence that includes offices in the USA, UK, and several other countries, Macleods Pharmaceuticals is dedicated to providing quality medicines to healthcare providers, hospitals, and pharmacies worldwide.


23. Amoun Pharmaceutical Company

  • Website: amoun.com
  • Ownership type: Corporate
  • Headquarters: Al Waili Al Kabir Sharq, Cairo Governorate, Egypt
  • Employee distribution: Egypt 97%, Other 3%
  • Latest funding: $740.0M, March 2021
  • Founded year: 1998
  • Headcount: 1001-5000
  • LinkedIn: amoun-pharmaceutical-industries-company

Amoun Pharmaceutical Company S.A.E. is an Egyptian Joint-Stock Company established in 1998, headquartered in El Obour City, Egypt. The company specializes in the development, manufacturing, marketing, and distribution of high-quality pharmaceutical products. With a workforce of over 2,500 employees, Amoun operates one of the largest pharmaceutical manufacturing facilities in Africa and the Middle East, utilizing advanced technology to ensure product quality and safety. The company has a strong commitment to improving healthcare outcomes, focusing on essential therapies and treatments. Amoun has expanded its reach beyond Egypt, exporting to over 29 countries and maintaining a portfolio of more than 230 registered products. In 2021, the company was acquired by Abu Dhabi Developmental Holding Company (ADQ), which has further strengthened its position in the industry. Amoun's sales have shown impressive growth, with a compounded annual growth rate of 18% over the past five years, reflecting its ability to adapt and thrive in a competitive market.


24. Sanofi Belgium

  • Website: sanofi.be
  • Ownership type: Private
  • Headquarters: Machelen, Flanders, Belgium
  • Employee distribution: Belgium 99%
  • Founded year: 2004
  • Headcount: 501-1000
  • LinkedIn: sanofi-belgium

Sanofi Belgium, established in 2004 and located in Machelen, Flanders, is a private pharmaceutical company that plays a vital role in the healthcare landscape. With approximately 1,600 employees across four sites in Belgium, Sanofi Belgium covers the entire pharmaceutical value chain. This includes research and development, clinical studies, production of biological medicines, and the commercialization and distribution of these products. The company is particularly focused on addressing chronic and rare diseases, showcasing a strong commitment to improving health outcomes. Their Geel facility is notable for producing therapeutic proteins and monoclonal antibodies, while the Ghent site is dedicated to developing innovative therapeutic technologies. Sanofi Belgium's ongoing investments, such as the €120 million allocated for expanding biomedicine production capacity, further highlight their dedication to advancing healthcare solutions.



Specialty Pharmaceutical Manufacturing Insights: Key Companies


CompanyHeadquarterSizeFoundedOwnership
Intas PharmaceuticalsAhmedabad, Gujarat, India10001+2000Private Equity
Chiesi GroupParma, Emilia-Romagna, Italy5001-100001935Private
Seattle GeneticsBothell, Washington, United States (USA)1001-50001998Private
Eisai Co., Ltd.Bunkyo City, Tokyo, Japan1001-50001941Private
Blau FarmacêuticaCotia, Sao Paulo, Brazil1001-50001987Private
Kedrion BiopharmaFort Lee, New Jersey, United States (USA)1001-50002001Private Equity
Par PharmaceuticalChestnut Ridge, New York, United States (USA)501-10001978Corporate
Acceleron PharmaCambridge, Massachusetts, United States (USA)201-5002003Corporate
NPS PharmaBedminster, New Jersey, United States (USA)201-5001986Corporate
EsteveBarcelona, Catalonia, Spain1001-50001929Corporate
EUSA PharmaHemel Hempstead, England, United Kingdom (UK)201-5002006Corporate
Laboratorios BagóGeneral Pacheco, Buenos Aires, Argentina5001-100001934Private
PROBIOMED S.A. de C.V.Mexico501-10001970Corporate
MundipharmaCambridge, England, United Kingdom (UK)1001-50001952Corporate
Medexus PharmaceuticalsChicago, Illinois, United States (USA)51-2002012Private
Zodiac Produtos FarmacêuticosSao Paulo, Sao Paulo, Brazil501-10001991Private
Adamed PharmaWarsaw, Masovian Voivodeship, Poland1001-50001986Private
MSD Sharp & Dohme GmbHAmt Neuhaus, Lower Saxony, Germany1001-50002001Private
GSK CanadaMississauga, Ontario, Canada1001-50001906Private
Italfarmaco S.P.A.Cinisello Balsamo, Lombardy, Italy501-10001938Family Owned
DompéMilan, Lombardy, Italy501-10001940Private
Macleods Pharmaceuticals LTD.Mumbai, Maharashtra, India10001+1989Private
Amoun Pharmaceutical CompanyAl Waili Al Kabir Sharq, Cairo Governorate, Egypt1001-50001998Corporate
Sanofi BelgiumMachelen, Flanders, Belgium501-10002004Private


Want to Find More Specialty Pharmaceutical Manufacturing Companies?

If you want to find more companies that offer treatments for unique medical conditions and chronic diseases you can do so with Inven. This list was built with Inven and there are hundreds of companies like these globally.

With Inven you'll also get to know the company's:

  • Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
  • Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
  • Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!